updates from the phase iii keynote-061 trial
Published 4 years ago • 98 plays • Length 6:57Download video MP4
Download video MP3
Similar videos
-
1:55
dr. yoon on updated results of the keynote-061 study in advanced gastric/gej cancer
-
1:10
keynote-811: hrqol pembro plus tras and chemo in first-line her2 advanced gastric cancer
-
4:52
asco gi 2021: trial updates
-
0:39
phase i/ii study of adapt-001 plus an ici for patients with immune refractory cancers
-
1:23
dr. zalupski on implications of the keynote-061 trial in gastric cancer
-
4:41
destiny-gastric03: trastuzumab deruxtecan in her2-overexpressing gastric cancer
-
36:14
tumor immunology
-
1:04:22
immunotherapy management of early and advanced gastric, esophageal, gej, and colorectal cancers
-
0:33
keynote-966: pembrolizumab gem/cis vs gemc/cis alone in advanced biliary tract cancer
-
1:33
biomarker analysis of the clear & keynote-426 trials in arcc
-
4:35
keynote-062: pembrolizumab vs. chemo in 1l advanced gastric cancer
-
1:43
understanding variant histologies in urothelial carcinoma: io and cabozantinib's potential
-
1:30
results of the phase ii geparnuevo trial
-
2:57
key data from the san antonio breast cancer symposium (sabcs) 2022
-
30:31
gastroesophageal cancer: current positioning of immunotherapy
-
1:07
recent breast cancer updates from sabcs 2021
-
1:40
keynote-811: trastuzumab chemotherapy with or without pembrolizumab for her2 g/gej cancer
-
3:57
pembrolizumab plus 5-fu and cisplatin for first-line treatment in...
-
2:14
comment: keynote 522 trial
-
1:21
dr. shah on the rationale for the keynote-590 trial in esophageal carcinoma
-
0:33
keynote-716: pembrolizumab in stage 2b/2c cutaneous melanoma
-
3:30
adaura: osimertinib adjuvant therapy on cns disease recurrence